Neurosurgery Residency Program
Cerebrovascular Surgery Trials:
PRET: Patients Prone to Recurrence after Endovascular Treatment: A Randomized Trial Comparing Platinum and Hydrogel-coated coils
Penumbra: A Multicenter Trial to Assess Outcome of Patients Revascularized by the Penumbra System
PAC Study: Evaluation of PresidioÆ and CerecyteÆ Coils in Large and Giant Aneurysms
Siemens Dyna-CT with Stoney Brooke: Validation of Dyna-CT Perfusion in Patients with Ischemic Cerebrovascular Disease
Siemens Dyna-CT with Stoney Brooke: Validation of Dyna-CT Perfusion in Patients with Severe Ischemic Cerebrovascular Disease
START: Clinical Outcome in Acute Stroke Treatment After Image Guided Patient Selection for Interventional Revascularization Therapy (START Trial)
Vasospasm study (Chaudry)
Gel-the-Neck: Gaining Efficacy Long Term: Hydrosoft, an Emerging, New, Embolic Coil(Gel-the-nec) A prospective registry evaluating the safety, ease of use, and efficacy of the HydroSoft Coil as a finishing device
Conscious III: A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling
PSAS: PACKING DENSITY IN SMALLER ANEURYSMS: HOW SIGNIFICANT?
MAPS: Matrix(R) And Platinum Science A Prospective, Randomized, Multicenter Trial Investigating Matrix2(R) Coils and GDC(R) Coils For the Treatment of Intracranial Saccular Aneurysms
HCAT: Hydrocoil Cerecyte Aneurysm Treatment Trial (H-CAT)
IMS-III: The Interventional Management of Stroke (IMS III) Trial is a randomized, open-label multi-center study that will compare a combined intravenous (IV) and intra-arterial (IA) treatment approach to restoring blood flow to the brain to the current standard FDA approved treatment approach of giving IV rt-PA alteplase, ActivaseÆ/ ActilyseÆ alone.
SAMMPRIS:The purpose of the SAMMPRIS study is to compare the safety and effectiveness of either Intensive Medical Therapy PLUS Stenting or Intensive Medical Therapy alone to prevent stroke, heart attack or death in patients with narrowed brain blood vessels.
For information regarding ongoing Neuro-Oncology clinical trials please refer to this link.
For information regarding ongoing Spine clinical trials please refer to this link.